The Association between Serum Cytokine and Chemokine Levels and Antiviral Response by Entecavir Treatment in Chronic Hepatitis B Patients
Author(s) -
Mio Kurihara,
Masataka Tsuge,
Eisuke Murakami,
Nami Mori,
Waka Ohishi,
Takuro Uchida,
Hatsue Fujino,
Takashi Nakahara,
Hiromi AbeChayama,
Tomokazu Kawaoka,
Daiki Miki,
Akira Hiramatsu,
Michio Imamura,
Yoshiiku Kawakami,
Hiroshi Aikata,
Hidenori Ochi,
Yizhou Zhang,
Grace Naswa Makokha,
C. Nelson Hayes,
Kazuaki Chayama
Publication year - 2017
Publication title -
antiviral therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.747
H-Index - 87
eISSN - 2040-2058
pISSN - 1359-6535
DOI - 10.3851/imp3196
Subject(s) - entecavir , medicine , hbsag , immunology , hbeag , chemokine , hepatitis b , cytokine , hepatitis b virus , gastroenterology , immune system , lamivudine , virus
Results of the present study indicate that changes in cytokine/chemokine levels following entecavir therapy are associated with response to antiviral therapy in CHB patients. Monitoring of serum cytokine/chemokine levels could be useful for predicting reduction of HBV DNA and HBsAg and HBe seroconversion.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom